Andrew J. Lightfoot

913 total citations
25 papers, 675 citations indexed

About

Andrew J. Lightfoot is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Andrew J. Lightfoot has authored 25 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Andrew J. Lightfoot's work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (8 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Andrew J. Lightfoot is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (8 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Andrew J. Lightfoot collaborates with scholars based in United States and Germany. Andrew J. Lightfoot's co-authors include Henry Rosevear, Michael A. O’Donnell, Kenneth G. Nepple, Thomas S. Griffith, Annunziato Amendola, Donald L. Lamm, Timothy P. Kresowik, Chad R. Tracy, Benjamin N. Breyer and Bradley A. Erickson and has published in prestigious journals such as PLoS ONE, The American Journal of Sports Medicine and The Journal of Urology.

In The Last Decade

Andrew J. Lightfoot

25 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew J. Lightfoot United States 16 409 178 177 129 98 25 675
Janusz Dembowski Poland 15 227 0.6× 136 0.8× 65 0.4× 150 1.2× 51 0.5× 52 509
Cono Scaffa Italy 21 317 0.8× 102 0.6× 152 0.9× 23 0.2× 157 1.6× 70 1.2k
Ó. Rodríguez Faba Spain 15 681 1.7× 266 1.5× 257 1.5× 207 1.6× 166 1.7× 94 1.1k
B. Klein Israel 12 321 0.8× 135 0.8× 67 0.4× 16 0.1× 209 2.1× 40 629
Yoshitaka Itami Japan 11 188 0.5× 100 0.6× 80 0.5× 31 0.2× 174 1.8× 38 409
T. Vögeli Germany 11 362 0.9× 159 0.9× 113 0.6× 148 1.1× 94 1.0× 20 594
T.S. O'Brien United Kingdom 10 225 0.6× 84 0.5× 182 1.0× 21 0.2× 87 0.9× 22 555
E. Becht Germany 9 225 0.6× 89 0.5× 153 0.9× 78 0.6× 54 0.6× 18 448
Alfred Krebs United States 8 121 0.3× 123 0.7× 65 0.4× 35 0.3× 29 0.3× 13 388
Keita Kobayashi Japan 15 274 0.7× 151 0.8× 130 0.7× 27 0.2× 108 1.1× 73 659

Countries citing papers authored by Andrew J. Lightfoot

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Lightfoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Lightfoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Lightfoot more than expected).

Fields of papers citing papers by Andrew J. Lightfoot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Lightfoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Lightfoot. The network helps show where Andrew J. Lightfoot may publish in the future.

Co-authorship network of co-authors of Andrew J. Lightfoot

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Lightfoot. A scholar is included among the top collaborators of Andrew J. Lightfoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Lightfoot. Andrew J. Lightfoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Llukani, Elton, Benjamin Katz, Ilir Agalliu, et al.. (2017). Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer. Prostate International. 5(1). 17–23. 10 indexed citations
2.
Su, Yu-Kai, Benjamin Katz, Yuchen Su, et al.. (2015). Does previous transurethral prostate surgery affect oncologic and continence outcomes after RARP?. Journal of Robotic Surgery. 9(4). 291–297. 15 indexed citations
3.
Lee, Ziho, Andrew J. Lightfoot, Phillip Mucksavage, & David I. Lee. (2015). Can robot-assisted radical prostatectomy be taught to chief residents and fellows without affecting operative outcomes?. Prostate International. 3(2). 47–50. 15 indexed citations
4.
Lightfoot, Andrew J., Yu-Kai Su, Ziho Lee, et al.. (2014). Positive Surgical Margin Trends in Patients with Pathologic T 3 Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy. Journal of Endourology. 29(6). 634–639. 14 indexed citations
5.
Lightfoot, Andrew J., Benjamin N. Breyer, Henry Rosevear, et al.. (2013). Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(1). 35.e15–35.e19. 85 indexed citations
6.
Lightfoot, Andrew J., Henry Rosevear, Kenneth G. Nepple, & Michael A. O’Donnell. (2012). Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high‐grade non‐muscle invasive bladder cancer. International Journal of Urology. 19(11). 988–993. 13 indexed citations
7.
Norian, Lyse A., Timothy P. Kresowik, Henry Rosevear, et al.. (2012). Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy. PLoS ONE. 7(2). e31085–e31085. 42 indexed citations
8.
Lightfoot, Andrew J., Henry Rosevear, William D. Steers, & Chad R. Tracy. (2011). Current and Future Need for Academic Urologists in the United States. The Journal of Urology. 185(6). 2283–2287. 12 indexed citations
9.
Rosevear, Henry, Paul T. Gellhaus, Andrew J. Lightfoot, et al.. (2011). Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk. British Journal of Urology. 109(5). 700–705. 74 indexed citations
10.
Rosevear, Henry, Hadyn T. Williams, Matthew H. Collins, et al.. (2011). Utility of 18F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. Urologic Oncology Seminars and Original Investigations. 30(5). 723–726. 15 indexed citations
11.
Rosevear, Henry, Andrew J. Lightfoot, Kenneth G. Nepple, & Michael A. O’Donnell. (2010). Safety and Efficacy of Intravesical Bacillus Calmette-Guérin Plus Interferon α-2b Therapy for Nonmuscle Invasive Bladder Cancer in Patients With Prosthetic Devices. The Journal of Urology. 184(5). 1920–1924. 8 indexed citations
12.
Rosevear, Henry, Andrew J. Lightfoot, Kenneth G. Nepple, & Michael A. O’Donnell. (2010). Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α. The Journal of Urology. 185(1). 67–71. 21 indexed citations
13.
14.
Rosevear, Henry, Andrew J. Lightfoot, & Thomas S. Griffith. (2010). Conatumumab, a fully human mAb against death receptor 5 for the treatment of cancer.. PubMed. 11(6). 688–98. 26 indexed citations
15.
Lightfoot, Andrew J., Henry Rosevear, & Karl J. Kreder. (2010). Inflatable penile prostheses: an update. Current Opinion in Urology. 20(6). 459–464. 4 indexed citations
16.
Rosevear, Henry, et al.. (2010). Lessons Learned from a Case of Calf Compartment Syndrome After Robot-Assisted Laparoscopic Prostatectomy. Journal of Endourology. 24(10). 1597–1601. 17 indexed citations
17.
Rosevear, Henry, Andrew J. Lightfoot, Michael A. O’Donnell, & Thomas S. Griffith. (2009). The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette–Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder. Cancer and Metastasis Reviews. 28(3-4). 345–353. 43 indexed citations
18.
Lightfoot, Andrew J., et al.. (2007). Treatment of Postoperative Ileus After Bowel Surgery with Low-Dose Intravenous Erythromycin. Urology. 69(4). 611–615. 28 indexed citations
19.
Lightfoot, Andrew J., et al.. (2005). ACL tears in collegiate wrestlers: report of six cases in one season.. PubMed. 25. 145–8. 14 indexed citations
20.
Saltzman, Charles L., Andrew J. Lightfoot, & Annunziato Amendola. (2004). PEMF as Treatment for Delayed Healing of Foot and Ankle Arthrodesis. Foot & Ankle International. 25(11). 771–773. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janusz Dembowski Breakdown of academic impact, for papers by Cono Scaffa Breakdown of academic impact, for papers by Ó. Rodríguez Faba Breakdown of academic impact, for papers by B. Klein Breakdown of academic impact, for papers by Yoshitaka Itami Breakdown of academic impact, for papers by T. Vögeli Breakdown of academic impact, for papers by T.S. O'Brien Breakdown of academic impact, for papers by E. Becht Breakdown of academic impact, for papers by Alfred Krebs Breakdown of academic impact, for papers by Keita Kobayashi
Rankless by CCL
2026